Customized research for MLNT vs. OCPNY!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for MLNT vs. OCPNY.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Melinta Therapeutics Inc. vs. Olympus Corporation

MLNT
Data Last Updated: More than 6 mos ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 6.875M


P/E: N/A

P/S: 0.07

Q P/B: N/A

Y Rev: 96.43M

Q Rev: 15.87M

Beta: 6.44

Industry

Health Care/Life Sciences

MLNT Share Stats

Outstanding Shares

11.78M

Float Shares

10.37M

Percent of Float Short

20.95%

MLNT Insider Stats

Percent Outstanding Insider Ownership

8.55%

Percent Outstanding Institution Ownership

24.45%

MLNT Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

MLNT in Pulse Portal

Stream of Posts

MLNT Symbol Page

Share MLNT Insights

Express Sentiment

'Buy' or 'Sell' MLNT

MLNT Profile

CEO

Ms. Jennifer A. Sanfilippo

Exchange

Nasdaq

Employees

290.00

About

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv,...

MLNT Financials

Annual Financials

Income Statement

Revenue

96.43M

Net Income

(157.19M)

Cash Flow Statement

Change in Cash / Investments

(46.58M)

Balance Sheet

Cash / Investments

81.81M

Short Term Debt

None

Long Term Debt

110.48M

Total Current Assets

149.48M

Total Current Liabilities

133.61M

Total Assets

441.59M

Total Liabilities

251.53M

Stockholder Equity

190.06M

Quarterly Financials

Income Statement

Q Revenue

15.87M

Q Net Income

(213.38M)

Cash Flow Statement

Q Change in Cash / Investments

(26.82M)

Balance Sheet

Q Cash / Investments

63.52M

Q Short Term Debt

7.82M

Q Long Term Debt

152.79M

Q Total Current Assets

131.27M

Q Total Current Liabilities

128.05M

Q Total Assets

228.49M

Q Total Liabilities

289.02M

Q Stockholder Equity

(60.53M)

MLNT Charts

10-Year Chart

MLNT 10-Year Chart

5-Year Chart

MLNT 5-Year Chart

1-Year Chart

MLNT 1-Year Chart

6-Month Chart

MLNT 6-Month Chart

3-Month Chart

MLNT 3-Month Chart

1-Month Chart

MLNT 1-Month Chart

1-Day Chart

MLNT 1-Day Chart

OCPNY
Data Last Updated: More than 2 wks ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 22.791B


P/E: 30.92

P/S: 0.03

Q P/B: 0.06

Y Rev: 797.41B

Q Rev: 202.34B

Beta: 0.92

Industry

5,853

OCPNY Share Stats

Outstanding Shares

1.37B

Float Shares

N/A

Percent of Float Short

N/A

OCPNY Insider Stats

Percent Outstanding Insider Ownership

0%

Percent Outstanding Institution Ownership

0.01%

OCPNY Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

OCPNY in Pulse Portal

Stream of Posts

OCPNY Symbol Page

Share OCPNY Insights

Express Sentiment

'Buy' or 'Sell' OCPNY

OCPNY Profile

CEO

Mr. Yasuo Takeuchi

Exchange

OTC

Employees

N/A

About

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. Th...

OCPNY Financials

Annual Financials

Income Statement

Revenue

797.41B

Net Income

51.66B

Cash Flow Statement

Change in Cash / Investments

48.15B

Balance Sheet

Cash / Investments

162.49B

Short Term Debt

81.02B

Long Term Debt

199.9B

Total Current Assets

506.71B

Total Current Liabilities

333.77B

Total Assets

1.02T

Total Liabilities

643.71B

Stockholder Equity

370.75B

Quarterly Financials

Income Statement

Q Revenue

202.34B

Q Net Income

(7.49B)

Cash Flow Statement

Q Change in Cash / Investments

17.87B

Balance Sheet

Q Cash / Investments

162.49B

Q Short Term Debt

81.02B

Q Long Term Debt

199.9B

Q Total Current Assets

506.71B

Q Total Current Liabilities

333.77B

Q Total Assets

1.02T

Q Total Liabilities

643.71B

Q Stockholder Equity

370.75B

OCPNY Charts

10-Year Chart

OCPNY 10-Year Chart

5-Year Chart

OCPNY 5-Year Chart

1-Year Chart

OCPNY 1-Year Chart

6-Month Chart

OCPNY 6-Month Chart

3-Month Chart

OCPNY 3-Month Chart

1-Month Chart

OCPNY 1-Month Chart

1-Day Chart

OCPNY 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon